nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—Phototoxicity—Dapsone—leprosy	0.0467	0.0478	CcSEcCtD
Moxifloxacin—Cholangitis—Thalidomide—leprosy	0.0264	0.0271	CcSEcCtD
Moxifloxacin—TOP2A—Menadione—Thalidomide—leprosy	0.023	1	CbGdCrCtD
Moxifloxacin—Peritonitis—Thalidomide—leprosy	0.0181	0.0186	CcSEcCtD
Moxifloxacin—Suicide attempt—Dapsone—leprosy	0.0158	0.0162	CcSEcCtD
Moxifloxacin—Hypoproteinaemia—Thalidomide—leprosy	0.0156	0.016	CcSEcCtD
Moxifloxacin—Lipase increased—Thalidomide—leprosy	0.0156	0.016	CcSEcCtD
Moxifloxacin—Polyneuropathy—Thalidomide—leprosy	0.0141	0.0144	CcSEcCtD
Moxifloxacin—Pyuria—Thalidomide—leprosy	0.0131	0.0134	CcSEcCtD
Moxifloxacin—Albuminuria—Dapsone—leprosy	0.012	0.0123	CcSEcCtD
Moxifloxacin—Hypochromic anaemia—Thalidomide—leprosy	0.0118	0.0121	CcSEcCtD
Moxifloxacin—Fungal skin infection—Thalidomide—leprosy	0.011	0.0112	CcSEcCtD
Moxifloxacin—Dysaesthesia—Thalidomide—leprosy	0.0106	0.0108	CcSEcCtD
Moxifloxacin—Aphthous stomatitis—Thalidomide—leprosy	0.00978	0.01	CcSEcCtD
Moxifloxacin—Hernia—Thalidomide—leprosy	0.00978	0.01	CcSEcCtD
Moxifloxacin—Grand mal convulsion—Thalidomide—leprosy	0.00963	0.00985	CcSEcCtD
Moxifloxacin—Tongue discolouration—Thalidomide—leprosy	0.00948	0.00971	CcSEcCtD
Moxifloxacin—Peripheral vascular disorder—Thalidomide—leprosy	0.00935	0.00957	CcSEcCtD
Moxifloxacin—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.00896	0.00917	CcSEcCtD
Moxifloxacin—Vesiculobullous rash—Thalidomide—leprosy	0.00818	0.00837	CcSEcCtD
Moxifloxacin—Suicide attempt—Thalidomide—leprosy	0.00808	0.00827	CcSEcCtD
Moxifloxacin—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.00789	0.00807	CcSEcCtD
Moxifloxacin—Enlargement abdomen—Thalidomide—leprosy	0.00762	0.0078	CcSEcCtD
Moxifloxacin—Psoriasis—Thalidomide—leprosy	0.00729	0.00746	CcSEcCtD
Moxifloxacin—Myasthenia—Thalidomide—leprosy	0.00729	0.00746	CcSEcCtD
Moxifloxacin—Oral candidiasis—Thalidomide—leprosy	0.00722	0.00739	CcSEcCtD
Moxifloxacin—Galactorrhoea—Thalidomide—leprosy	0.00707	0.00723	CcSEcCtD
Moxifloxacin—Menstrual disorder—Thalidomide—leprosy	0.00672	0.00688	CcSEcCtD
Moxifloxacin—Lung disorder—Thalidomide—leprosy	0.00648	0.00663	CcSEcCtD
Moxifloxacin—Hyperlipidaemia—Thalidomide—leprosy	0.00636	0.00651	CcSEcCtD
Moxifloxacin—Psychotic disorder—Dapsone—leprosy	0.00635	0.0065	CcSEcCtD
Moxifloxacin—Albuminuria—Thalidomide—leprosy	0.00614	0.00628	CcSEcCtD
Moxifloxacin—Pleural effusion—Thalidomide—leprosy	0.00599	0.00613	CcSEcCtD
Moxifloxacin—Amblyopia—Thalidomide—leprosy	0.00594	0.00608	CcSEcCtD
Moxifloxacin—Skin ulcer—Thalidomide—leprosy	0.00589	0.00603	CcSEcCtD
Moxifloxacin—Hyperaesthesia—Thalidomide—leprosy	0.00584	0.00598	CcSEcCtD
Moxifloxacin—Rash pustular—Thalidomide—leprosy	0.00575	0.00588	CcSEcCtD
Moxifloxacin—Muscular weakness—Dapsone—leprosy	0.00573	0.00587	CcSEcCtD
Moxifloxacin—Myocardial ischaemia—Thalidomide—leprosy	0.0057	0.00584	CcSEcCtD
Moxifloxacin—Pancreatitis—Dapsone—leprosy	0.00551	0.00564	CcSEcCtD
Moxifloxacin—Apnoea—Thalidomide—leprosy	0.00541	0.00553	CcSEcCtD
Moxifloxacin—Jaundice cholestatic—Thalidomide—leprosy	0.00522	0.00534	CcSEcCtD
Moxifloxacin—Vasodilation procedure—Thalidomide—leprosy	0.00522	0.00534	CcSEcCtD
Moxifloxacin—Vasodilation—Thalidomide—leprosy	0.00522	0.00534	CcSEcCtD
Moxifloxacin—Photosensitivity reaction—Dapsone—leprosy	0.00513	0.00525	CcSEcCtD
Moxifloxacin—Bone disorder—Thalidomide—leprosy	0.00508	0.00519	CcSEcCtD
Moxifloxacin—Cellulitis—Thalidomide—leprosy	0.00504	0.00516	CcSEcCtD
Moxifloxacin—Arthropathy—Thalidomide—leprosy	0.00504	0.00516	CcSEcCtD
Moxifloxacin—Hyperbilirubinaemia—Thalidomide—leprosy	0.00504	0.00516	CcSEcCtD
Moxifloxacin—Thinking abnormal—Thalidomide—leprosy	0.00501	0.00513	CcSEcCtD
Moxifloxacin—Herpes simplex—Thalidomide—leprosy	0.00497	0.00509	CcSEcCtD
Moxifloxacin—Hyperuricaemia—Thalidomide—leprosy	0.00494	0.00506	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Dapsone—leprosy	0.00491	0.00503	CcSEcCtD
Moxifloxacin—Leukocytosis—Thalidomide—leprosy	0.00488	0.00499	CcSEcCtD
Moxifloxacin—Hypercholesterolaemia—Thalidomide—leprosy	0.00485	0.00496	CcSEcCtD
Moxifloxacin—Hearing impaired—Thalidomide—leprosy	0.00482	0.00493	CcSEcCtD
Moxifloxacin—Sinusitis—Dapsone—leprosy	0.0047	0.00481	CcSEcCtD
Moxifloxacin—Gait disturbance—Thalidomide—leprosy	0.0047	0.00481	CcSEcCtD
Moxifloxacin—Blood uric acid increased—Thalidomide—leprosy	0.00467	0.00478	CcSEcCtD
Moxifloxacin—Coordination abnormal—Thalidomide—leprosy	0.00467	0.00478	CcSEcCtD
Moxifloxacin—Hepatocellular injury—Thalidomide—leprosy	0.00458	0.00469	CcSEcCtD
Moxifloxacin—Eructation—Thalidomide—leprosy	0.0045	0.00461	CcSEcCtD
Moxifloxacin—Pharyngitis—Dapsone—leprosy	0.00446	0.00457	CcSEcCtD
Moxifloxacin—Colitis—Thalidomide—leprosy	0.0044	0.0045	CcSEcCtD
Moxifloxacin—Candida infection—Thalidomide—leprosy	0.00438	0.00448	CcSEcCtD
Moxifloxacin—Blood urea increased—Thalidomide—leprosy	0.00433	0.00443	CcSEcCtD
Moxifloxacin—Neuropathy—Thalidomide—leprosy	0.0043	0.00441	CcSEcCtD
Moxifloxacin—Dry eye—Thalidomide—leprosy	0.00423	0.00433	CcSEcCtD
Moxifloxacin—Cramps of lower extremities—Thalidomide—leprosy	0.00421	0.00431	CcSEcCtD
Moxifloxacin—Tinnitus—Dapsone—leprosy	0.00419	0.00429	CcSEcCtD
Moxifloxacin—Oesophagitis—Thalidomide—leprosy	0.00419	0.00429	CcSEcCtD
Moxifloxacin—Rash maculo-papular—Thalidomide—leprosy	0.00417	0.00426	CcSEcCtD
Moxifloxacin—Hypertonia—Thalidomide—leprosy	0.00402	0.00411	CcSEcCtD
Moxifloxacin—Hyperkinesia—Thalidomide—leprosy	0.004	0.00409	CcSEcCtD
Moxifloxacin—Mental disability—Thalidomide—leprosy	0.00398	0.00407	CcSEcCtD
Moxifloxacin—Sepsis—Thalidomide—leprosy	0.00398	0.00407	CcSEcCtD
Moxifloxacin—Euphoric mood—Thalidomide—leprosy	0.00394	0.00403	CcSEcCtD
Moxifloxacin—Erythema—Dapsone—leprosy	0.00391	0.00401	CcSEcCtD
Moxifloxacin—Thrombophlebitis—Thalidomide—leprosy	0.00384	0.00393	CcSEcCtD
Moxifloxacin—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00383	0.00392	CcSEcCtD
Moxifloxacin—Diabetes mellitus—Thalidomide—leprosy	0.00383	0.00392	CcSEcCtD
Moxifloxacin—Photosensitivity—Thalidomide—leprosy	0.00379	0.00388	CcSEcCtD
Moxifloxacin—Gastroenteritis—Thalidomide—leprosy	0.00375	0.00384	CcSEcCtD
Moxifloxacin—Deafness—Thalidomide—leprosy	0.00372	0.00381	CcSEcCtD
Moxifloxacin—Eczema—Thalidomide—leprosy	0.0037	0.00379	CcSEcCtD
Moxifloxacin—Vision blurred—Dapsone—leprosy	0.00369	0.00378	CcSEcCtD
Moxifloxacin—Eye pain—Thalidomide—leprosy	0.00369	0.00377	CcSEcCtD
Moxifloxacin—Cardiac failure congestive—Thalidomide—leprosy	0.00367	0.00376	CcSEcCtD
Moxifloxacin—Injury—Thalidomide—leprosy	0.00362	0.00371	CcSEcCtD
Moxifloxacin—Renal failure acute—Thalidomide—leprosy	0.0036	0.00369	CcSEcCtD
Moxifloxacin—Amnesia—Thalidomide—leprosy	0.00354	0.00363	CcSEcCtD
Moxifloxacin—Increased appetite—Thalidomide—leprosy	0.00354	0.00363	CcSEcCtD
Moxifloxacin—Vertigo—Dapsone—leprosy	0.00352	0.0036	CcSEcCtD
Moxifloxacin—Visual disturbance—Thalidomide—leprosy	0.00351	0.00359	CcSEcCtD
Moxifloxacin—Atrial fibrillation—Thalidomide—leprosy	0.00351	0.00359	CcSEcCtD
Moxifloxacin—Dermatitis bullous—Thalidomide—leprosy	0.00348	0.00356	CcSEcCtD
Moxifloxacin—Purpura—Thalidomide—leprosy	0.00345	0.00353	CcSEcCtD
Moxifloxacin—Arthritis—Thalidomide—leprosy	0.00342	0.0035	CcSEcCtD
Moxifloxacin—Cough—Dapsone—leprosy	0.00342	0.0035	CcSEcCtD
Moxifloxacin—Cardiac failure—Thalidomide—leprosy	0.00341	0.00349	CcSEcCtD
Moxifloxacin—Hypoglycaemia—Thalidomide—leprosy	0.00341	0.00349	CcSEcCtD
Moxifloxacin—Cerebrovascular accident—Thalidomide—leprosy	0.0034	0.00348	CcSEcCtD
Moxifloxacin—Lethargy—Thalidomide—leprosy	0.0034	0.00348	CcSEcCtD
Moxifloxacin—Pain in extremity—Thalidomide—leprosy	0.00333	0.00341	CcSEcCtD
Moxifloxacin—Diplopia—Thalidomide—leprosy	0.00333	0.00341	CcSEcCtD
Moxifloxacin—Osteoarthritis—Thalidomide—leprosy	0.00333	0.00341	CcSEcCtD
Moxifloxacin—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00333	0.00341	CcSEcCtD
Moxifloxacin—Migraine—Thalidomide—leprosy	0.00328	0.00335	CcSEcCtD
Moxifloxacin—Affect lability—Thalidomide—leprosy	0.00328	0.00335	CcSEcCtD
Moxifloxacin—Psychotic disorder—Thalidomide—leprosy	0.00325	0.00333	CcSEcCtD
Moxifloxacin—Face oedema—Thalidomide—leprosy	0.00321	0.00329	CcSEcCtD
Moxifloxacin—Cardiac arrest—Thalidomide—leprosy	0.00316	0.00324	CcSEcCtD
Moxifloxacin—Mood swings—Thalidomide—leprosy	0.00315	0.00323	CcSEcCtD
Moxifloxacin—Tachycardia—Dapsone—leprosy	0.00312	0.00319	CcSEcCtD
Moxifloxacin—Blood creatinine increased—Thalidomide—leprosy	0.00312	0.00319	CcSEcCtD
Moxifloxacin—Dehydration—Thalidomide—leprosy	0.00309	0.00317	CcSEcCtD
Moxifloxacin—Liver function test abnormal—Thalidomide—leprosy	0.00307	0.00314	CcSEcCtD
Moxifloxacin—Dry skin—Thalidomide—leprosy	0.00305	0.00312	CcSEcCtD
Moxifloxacin—Orthostatic hypotension—Thalidomide—leprosy	0.00304	0.00311	CcSEcCtD
Moxifloxacin—Hypokalaemia—Thalidomide—leprosy	0.00303	0.0031	CcSEcCtD
Moxifloxacin—Breast disorder—Thalidomide—leprosy	0.00301	0.00308	CcSEcCtD
Moxifloxacin—Toxic epidermal necrolysis—Thalidomide—leprosy	0.003	0.00307	CcSEcCtD
Moxifloxacin—Cramp muscle—Thalidomide—leprosy	0.003	0.00307	CcSEcCtD
Moxifloxacin—Aspartate aminotransferase increased—Thalidomide—leprosy	0.003	0.00307	CcSEcCtD
Moxifloxacin—Alanine aminotransferase increased—Thalidomide—leprosy	0.00293	0.003	CcSEcCtD
Moxifloxacin—Muscular weakness—Thalidomide—leprosy	0.00293	0.003	CcSEcCtD
Moxifloxacin—Abdominal distension—Thalidomide—leprosy	0.0029	0.00296	CcSEcCtD
Moxifloxacin—Insomnia—Dapsone—leprosy	0.00289	0.00296	CcSEcCtD
Moxifloxacin—Dysphagia—Thalidomide—leprosy	0.00288	0.00294	CcSEcCtD
Moxifloxacin—Eosinophilia—Thalidomide—leprosy	0.00285	0.00291	CcSEcCtD
Moxifloxacin—Bronchospasm—Thalidomide—leprosy	0.00283	0.0029	CcSEcCtD
Moxifloxacin—Pancreatitis—Thalidomide—leprosy	0.00282	0.00289	CcSEcCtD
Moxifloxacin—Angina pectoris—Thalidomide—leprosy	0.0028	0.00287	CcSEcCtD
Moxifloxacin—Pancytopenia—Thalidomide—leprosy	0.00273	0.0028	CcSEcCtD
Moxifloxacin—Neutropenia—Thalidomide—leprosy	0.00269	0.00275	CcSEcCtD
Moxifloxacin—Pollakiuria—Thalidomide—leprosy	0.00266	0.00272	CcSEcCtD
Moxifloxacin—Photosensitivity reaction—Thalidomide—leprosy	0.00263	0.00269	CcSEcCtD
Moxifloxacin—Weight increased—Thalidomide—leprosy	0.00262	0.00268	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Dapsone—leprosy	0.00261	0.00267	CcSEcCtD
Moxifloxacin—Hyperglycaemia—Thalidomide—leprosy	0.00259	0.00266	CcSEcCtD
Moxifloxacin—Pneumonia—Thalidomide—leprosy	0.00258	0.00264	CcSEcCtD
Moxifloxacin—Infestation—Thalidomide—leprosy	0.00256	0.00262	CcSEcCtD
Moxifloxacin—Infestation NOS—Thalidomide—leprosy	0.00256	0.00262	CcSEcCtD
Moxifloxacin—Depression—Thalidomide—leprosy	0.00256	0.00262	CcSEcCtD
Moxifloxacin—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00254	0.0026	CcSEcCtD
Moxifloxacin—Acute coronary syndrome—Thalidomide—leprosy	0.00253	0.00259	CcSEcCtD
Moxifloxacin—Abdominal pain—Dapsone—leprosy	0.00253	0.00258	CcSEcCtD
Moxifloxacin—Body temperature increased—Dapsone—leprosy	0.00253	0.00258	CcSEcCtD
Moxifloxacin—Renal failure—Thalidomide—leprosy	0.00252	0.00258	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Thalidomide—leprosy	0.00251	0.00257	CcSEcCtD
Moxifloxacin—Myocardial infarction—Thalidomide—leprosy	0.00251	0.00257	CcSEcCtD
Moxifloxacin—Stomatitis—Thalidomide—leprosy	0.0025	0.00256	CcSEcCtD
Moxifloxacin—Conjunctivitis—Thalidomide—leprosy	0.00249	0.00255	CcSEcCtD
Moxifloxacin—Sweating—Thalidomide—leprosy	0.00246	0.00252	CcSEcCtD
Moxifloxacin—Haematuria—Thalidomide—leprosy	0.00244	0.0025	CcSEcCtD
Moxifloxacin—Epistaxis—Thalidomide—leprosy	0.00242	0.00248	CcSEcCtD
Moxifloxacin—Sinusitis—Thalidomide—leprosy	0.00241	0.00246	CcSEcCtD
Moxifloxacin—Agranulocytosis—Thalidomide—leprosy	0.00239	0.00245	CcSEcCtD
Moxifloxacin—Bradycardia—Thalidomide—leprosy	0.00234	0.0024	CcSEcCtD
Moxifloxacin—Rhinitis—Thalidomide—leprosy	0.00231	0.00236	CcSEcCtD
Moxifloxacin—Hepatitis—Thalidomide—leprosy	0.0023	0.00236	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Thalidomide—leprosy	0.00229	0.00234	CcSEcCtD
Moxifloxacin—Pharyngitis—Thalidomide—leprosy	0.00228	0.00234	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Thalidomide—leprosy	0.00227	0.00233	CcSEcCtD
Moxifloxacin—Oedema peripheral—Thalidomide—leprosy	0.00227	0.00232	CcSEcCtD
Moxifloxacin—Urethral disorder—Thalidomide—leprosy	0.00226	0.00231	CcSEcCtD
Moxifloxacin—Visual impairment—Thalidomide—leprosy	0.00222	0.00227	CcSEcCtD
Moxifloxacin—Erythema multiforme—Thalidomide—leprosy	0.00218	0.00223	CcSEcCtD
Moxifloxacin—Eye disorder—Thalidomide—leprosy	0.00215	0.0022	CcSEcCtD
Moxifloxacin—Tinnitus—Thalidomide—leprosy	0.00215	0.0022	CcSEcCtD
Moxifloxacin—Cardiac disorder—Thalidomide—leprosy	0.00214	0.00219	CcSEcCtD
Moxifloxacin—Angiopathy—Thalidomide—leprosy	0.00209	0.00214	CcSEcCtD
Moxifloxacin—Immune system disorder—Thalidomide—leprosy	0.00208	0.00213	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Thalidomide—leprosy	0.00207	0.00212	CcSEcCtD
Moxifloxacin—Chills—Thalidomide—leprosy	0.00207	0.00211	CcSEcCtD
Moxifloxacin—Arrhythmia—Thalidomide—leprosy	0.00206	0.0021	CcSEcCtD
Moxifloxacin—Vomiting—Dapsone—leprosy	0.00203	0.00208	CcSEcCtD
Moxifloxacin—Mental disorder—Thalidomide—leprosy	0.00202	0.00206	CcSEcCtD
Moxifloxacin—Malnutrition—Thalidomide—leprosy	0.002	0.00205	CcSEcCtD
Moxifloxacin—Headache—Dapsone—leprosy	0.002	0.00205	CcSEcCtD
Moxifloxacin—Flatulence—Thalidomide—leprosy	0.00197	0.00202	CcSEcCtD
Moxifloxacin—Tension—Thalidomide—leprosy	0.00197	0.00201	CcSEcCtD
Moxifloxacin—Dysgeusia—Thalidomide—leprosy	0.00196	0.00201	CcSEcCtD
Moxifloxacin—Nervousness—Thalidomide—leprosy	0.00195	0.00199	CcSEcCtD
Moxifloxacin—Back pain—Thalidomide—leprosy	0.00194	0.00198	CcSEcCtD
Moxifloxacin—Muscle spasms—Thalidomide—leprosy	0.00193	0.00197	CcSEcCtD
Moxifloxacin—Nausea—Dapsone—leprosy	0.0019	0.00194	CcSEcCtD
Moxifloxacin—Vision blurred—Thalidomide—leprosy	0.00189	0.00193	CcSEcCtD
Moxifloxacin—Tremor—Thalidomide—leprosy	0.00188	0.00192	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Thalidomide—leprosy	0.00186	0.0019	CcSEcCtD
Moxifloxacin—Anaemia—Thalidomide—leprosy	0.00185	0.0019	CcSEcCtD
Moxifloxacin—Agitation—Thalidomide—leprosy	0.00184	0.00188	CcSEcCtD
Moxifloxacin—Angioedema—Thalidomide—leprosy	0.00183	0.00187	CcSEcCtD
Moxifloxacin—Malaise—Thalidomide—leprosy	0.00181	0.00185	CcSEcCtD
Moxifloxacin—Vertigo—Thalidomide—leprosy	0.0018	0.00184	CcSEcCtD
Moxifloxacin—Syncope—Thalidomide—leprosy	0.0018	0.00184	CcSEcCtD
Moxifloxacin—Leukopenia—Thalidomide—leprosy	0.00179	0.00184	CcSEcCtD
Moxifloxacin—Palpitations—Thalidomide—leprosy	0.00177	0.00181	CcSEcCtD
Moxifloxacin—Loss of consciousness—Thalidomide—leprosy	0.00176	0.0018	CcSEcCtD
Moxifloxacin—Cough—Thalidomide—leprosy	0.00175	0.00179	CcSEcCtD
Moxifloxacin—Convulsion—Thalidomide—leprosy	0.00174	0.00178	CcSEcCtD
Moxifloxacin—Hypertension—Thalidomide—leprosy	0.00173	0.00177	CcSEcCtD
Moxifloxacin—Arthralgia—Thalidomide—leprosy	0.00171	0.00175	CcSEcCtD
Moxifloxacin—Chest pain—Thalidomide—leprosy	0.00171	0.00175	CcSEcCtD
Moxifloxacin—Myalgia—Thalidomide—leprosy	0.00171	0.00175	CcSEcCtD
Moxifloxacin—Anxiety—Thalidomide—leprosy	0.0017	0.00174	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00169	0.00173	CcSEcCtD
Moxifloxacin—Discomfort—Thalidomide—leprosy	0.00169	0.00173	CcSEcCtD
Moxifloxacin—Dry mouth—Thalidomide—leprosy	0.00167	0.00171	CcSEcCtD
Moxifloxacin—Confusional state—Thalidomide—leprosy	0.00165	0.00169	CcSEcCtD
Moxifloxacin—Oedema—Thalidomide—leprosy	0.00164	0.00167	CcSEcCtD
Moxifloxacin—Shock—Thalidomide—leprosy	0.00161	0.00165	CcSEcCtD
Moxifloxacin—Nervous system disorder—Thalidomide—leprosy	0.0016	0.00164	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Thalidomide—leprosy	0.0016	0.00164	CcSEcCtD
Moxifloxacin—Tachycardia—Thalidomide—leprosy	0.0016	0.00163	CcSEcCtD
Moxifloxacin—Skin disorder—Thalidomide—leprosy	0.00159	0.00163	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Thalidomide—leprosy	0.00158	0.00162	CcSEcCtD
Moxifloxacin—Anorexia—Thalidomide—leprosy	0.00156	0.0016	CcSEcCtD
Moxifloxacin—Hypotension—Thalidomide—leprosy	0.00153	0.00156	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Thalidomide—leprosy	0.00149	0.00153	CcSEcCtD
Moxifloxacin—Insomnia—Thalidomide—leprosy	0.00148	0.00151	CcSEcCtD
Moxifloxacin—Paraesthesia—Thalidomide—leprosy	0.00147	0.0015	CcSEcCtD
Moxifloxacin—Dyspnoea—Thalidomide—leprosy	0.00146	0.00149	CcSEcCtD
Moxifloxacin—Somnolence—Thalidomide—leprosy	0.00145	0.00149	CcSEcCtD
Moxifloxacin—Dyspepsia—Thalidomide—leprosy	0.00144	0.00147	CcSEcCtD
Moxifloxacin—Decreased appetite—Thalidomide—leprosy	0.00142	0.00146	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Thalidomide—leprosy	0.00141	0.00145	CcSEcCtD
Moxifloxacin—Fatigue—Thalidomide—leprosy	0.00141	0.00144	CcSEcCtD
Moxifloxacin—Constipation—Thalidomide—leprosy	0.0014	0.00143	CcSEcCtD
Moxifloxacin—Pain—Thalidomide—leprosy	0.0014	0.00143	CcSEcCtD
Moxifloxacin—Feeling abnormal—Thalidomide—leprosy	0.00135	0.00138	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Thalidomide—leprosy	0.00134	0.00137	CcSEcCtD
Moxifloxacin—Urticaria—Thalidomide—leprosy	0.0013	0.00133	CcSEcCtD
Moxifloxacin—Abdominal pain—Thalidomide—leprosy	0.00129	0.00132	CcSEcCtD
Moxifloxacin—Body temperature increased—Thalidomide—leprosy	0.00129	0.00132	CcSEcCtD
Moxifloxacin—Hypersensitivity—Thalidomide—leprosy	0.0012	0.00123	CcSEcCtD
Moxifloxacin—Asthenia—Thalidomide—leprosy	0.00117	0.0012	CcSEcCtD
Moxifloxacin—Pruritus—Thalidomide—leprosy	0.00116	0.00118	CcSEcCtD
Moxifloxacin—Diarrhoea—Thalidomide—leprosy	0.00112	0.00115	CcSEcCtD
Moxifloxacin—Dizziness—Thalidomide—leprosy	0.00108	0.00111	CcSEcCtD
Moxifloxacin—Vomiting—Thalidomide—leprosy	0.00104	0.00106	CcSEcCtD
Moxifloxacin—Rash—Thalidomide—leprosy	0.00103	0.00106	CcSEcCtD
Moxifloxacin—Dermatitis—Thalidomide—leprosy	0.00103	0.00105	CcSEcCtD
Moxifloxacin—Headache—Thalidomide—leprosy	0.00102	0.00105	CcSEcCtD
Moxifloxacin—Nausea—Thalidomide—leprosy	0.000971	0.000994	CcSEcCtD
